Collegium PharmaceuticalCompany Details

Get alertedif Collegium Pharmaceutical gets funded!
United States
Rhode Island
Industry:Medical devices and equipment
Detailed industries:biotechnology
Company description

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its patent-protected DETERx technology platform for the treatment of chronic pain. The DETERx oral drug delivery technology is designed to provide extended-release delivery, unique abuse-deterrent properties, and flexible dose administration options.


Funding history

Key people
Patrick FortuneDirector
Michael HeffernanCo-Founder, President, CEO, Director, Executive_Officer
Patrick HeronDirector
Stephen J. HoffmanBoard of Directors
Matthew StrobeckDirector
Michael T. HeffernanCo - Founder, President & CEO
Heow TanVice President of Technical Operations
Steven TannenbaumExecutive_Officer
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!